rs778291283
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001205293.3(CACNA1E):c.1807A>C(p.Ile603Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001205293.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.1807A>C | p.Ile603Leu | missense_variant | Exon 14 of 48 | 1 | NM_001205293.3 | ENSP00000356545.2 | ||
CACNA1E | ENST00000360108.7 | c.1807A>C | p.Ile603Leu | missense_variant | Exon 14 of 47 | 5 | ENSP00000353222.3 | |||
CACNA1E | ENST00000367570.6 | c.1807A>C | p.Ile603Leu | missense_variant | Exon 14 of 47 | 1 | ENSP00000356542.1 | |||
CACNA1E | ENST00000621791.4 | c.1807A>C | p.Ile603Leu | missense_variant | Exon 14 of 46 | 1 | ENSP00000481619.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 69 Pathogenic:2
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with developmental and epileptic encephalopathy 69 (MIM#618285; PMID: 30343943). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from isoleucine to leucine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2: 1 heterozygote, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions but in a highly conserved residue. (I) 0603 - Missense variant in a region that is highly intolerant to missense variation (high constraint region in DECIPHER) and in the domain II S4-S5 linker region (PMID: 30343943). (SP) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported as de novo in a child with focal motor seizures, hypotonia and severe developmental delay (PMID: 30343943). (SP) 0905 - No published segregation evidence has been identified for this variant. Causative CACNA1E variants have been reported as de novo in the published literature. (I) 1002 - Moderate functional evidence supporting abnormal protein function. Patch clamp studies show increased current density and hyperpolarisation shift in tsA201 cells with this variant compared with wild-type (PMID: 30343943). However, patch clamp assays have been shown to be unreliable and therefore, results from these studies are used with caution during variant classification. (I) 1102 - Strong phenotype match for this individual. (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) by trio analysis. (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
- -
not provided Pathogenic:1
The confirmed de novo I603L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant is not observed in large population cohorts (Lek et al., 2016; Exome Variant Server, 2016; McVean et al., 2012). The I603L variant is a conservative amino acid substitution that occurs at a conserved position predicted to be in the intracellular loop between the S4 and S5 transmembrane segments of the second homologous domain. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at